NPR blog examines 'test and treat' approach as HIV/AIDS prevention tactic

NPR's "Shots" blog examines the "test and treat" approach to HIV care and prevention, which "relies on the fact that taking HIV drugs dramatically reduces a person's risk of transmitting the virus to others," and, "[a]s more and more people are put on medication, the epidemic theoretically should fizzle out." The blog continues, "Test and treat sounds good on paper, but some doctors and policymakers have doubts about its feasibility on a large scale."

"An analysis just published in the journal PLoS One questions whether test and treat is the best strategy in developing countries, such as South Africa, where getting drugs to many people is difficult and the rise of drug resistance is a potential problem," "Shots" notes. The blog discusses a mathematical model developed by WHO to "look at how test and treat could alter the course of the HIV epidemic in South Africa" and writes, "Such questions can't be answered with theoretical models. Treatment strategies need to be evaluated experimentally with small projects." The blog adds, "WHO is using the results from these [small] projects and many modeling experiments to develop new guidelines for antiretroviral drugs. It plans to publish these guidelines in 2013" (Doucleff, 9/6).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    New insights into the mechanisms of efavirenz-induced neurotoxicity